132 related articles for article (PubMed ID: 35640539)
21. hsa_circ_0119412 overexpression promotes cervical cancer progression by targeting miR-217 to upregulate anterior gradient 2.
Lv Y; Wang M; Chen M; Wang D; Luo M; Zeng Q
J Clin Lab Anal; 2022 Apr; 36(4):e24236. PubMed ID: 35274779
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2.
Pan Q; Sun L; Zheng D; Li N; Shi H; Song J; Shao G; Xu G
Biomed Res Int; 2018; 2018():1769040. PubMed ID: 30175116
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing
Ai J; Sun J; Zhou G; Zhu T; Jing L
Cell Cycle; 2020 Apr; 19(7):742-757. PubMed ID: 32089066
[TBL] [Abstract][Full Text] [Related]
24. EIF5A2 is a novel chemoresistance gene in breast cancer.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Breast Cancer; 2015 Nov; 22(6):602-7. PubMed ID: 24638963
[TBL] [Abstract][Full Text] [Related]
25. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance.
Xu G; Chen H; Wu S; Chen J; Zhang S; Shao G; Sun L; Mu Y; Liu K; Pan Q; Li N; An X; Lin S; Chen W
Cell Death Dis; 2022 Aug; 13(8):683. PubMed ID: 35931669
[TBL] [Abstract][Full Text] [Related]
27. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
[TBL] [Abstract][Full Text] [Related]
28. TP53 mediated miR-3647-5p prevents progression of cervical carcinoma by targeting AGR2.
Liu R; Qian M; Zhou T; Cui P
Cancer Med; 2019 Oct; 8(13):6095-6105. PubMed ID: 31436390
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.
Zhu W; Cai MY; Tong ZT; Dong SS; Mai SJ; Liao YJ; Bian XW; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
Gut; 2012 Apr; 61(4):562-75. PubMed ID: 21813470
[TBL] [Abstract][Full Text] [Related]
30. The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2.
Zhuang S; Xie J; Zhen J; Guo L; Hong Z; Li F; Xu D
Mol Cell Endocrinol; 2021 Nov; 537():111440. PubMed ID: 34428509
[TBL] [Abstract][Full Text] [Related]
31. Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma.
Yang H; Li XD; Zhou Y; Ban X; Zeng TT; Li L; Zhang BZ; Yun J; Xie D; Guan XY; Li Y
Oncotarget; 2015 Sep; 6(28):26079-89. PubMed ID: 26317793
[TBL] [Abstract][Full Text] [Related]
32. The long noncoding RNA myocardial infarction-associated transcript modulates the epithelial-mesenchymal transition in renal interstitial fibrosis.
Wang Z; Zhang B; Chen Z; He Y; Ru F; Liu P; Chen X
Life Sci; 2020 Jan; 241():117187. PubMed ID: 31863776
[TBL] [Abstract][Full Text] [Related]
33. Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression.
Wang FW; Cai MY; Mai SJ; Chen JW; Bai HY; Li Y; Liao YJ; Li CP; Tian XP; Kung HF; Guan XY; Xie D
Oncotarget; 2014 Aug; 5(16):6716-33. PubMed ID: 25071013
[TBL] [Abstract][Full Text] [Related]
34. GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and eIF5A2 inactivation in mesenchymal phenotype oral cancer cells.
Fang L; Gao L; Xie L; Xiao G
Oncol Rep; 2018 Mar; 39(3):1283-1291. PubMed ID: 29286162
[TBL] [Abstract][Full Text] [Related]
35. EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo.
Wei JH; Cao JZ; Zhang D; Liao B; Zhong WM; Lu J; Zhao HW; Zhang JX; Tong ZT; Fan S; Liang CZ; Liao YB; Pang J; Wu RH; Fang Y; Chen ZH; Li B; Xie D; Chen W; Luo JH
Br J Cancer; 2014 Apr; 110(7):1767-77. PubMed ID: 24504366
[TBL] [Abstract][Full Text] [Related]
36. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
37. Eukaryotic Initiation Factor 5A2 Regulates Expression of Antiviral Genes.
Farache D; Liu L; Lee ASY
J Mol Biol; 2022 May; 434(10):167564. PubMed ID: 35358571
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer.
Zheng X; Gao L; Wang BT; Shen P; Yuan XF; Zhang LQ; Yang L; Zhang DP; Zhang Q; Wang XM
Histol Histopathol; 2020 Jun; 35(6):579-587. PubMed ID: 31745968
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p.
Liu C; Wang JO; Zhou WY; Chang XY; Zhang MM; Zhang Y; Yang XH
Mol Cell Endocrinol; 2019 Aug; 493():110424. PubMed ID: 30991076
[TBL] [Abstract][Full Text] [Related]
40. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of NSCLC cells to cetuximab through inhibition of eukaryotic translation initiation factor 5A2 activation.
Wang X; Jiang R; Cui EH; Feng WM; Guo HH; Gu DH; Tang CW; Xue T; Bao Y
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1244-50. PubMed ID: 27097942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
